Among the co-upregulated TFs in CRC, we highlight the MYC proto-oncogene (MYC), transcription factor 2 (TCF3), promyelocytic leukemia (PML), and to a less degree the SRY-box transcription factor 2 (SOX2). This evidence concerns the gene TCF3 and colorectal carcinoma.